Correction: Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin study (PLoS One (2017) 12:9 (e0184550) DOI: 10.1371/journal.pone.0184550)

  1. Buti, M.
  2. Manzano, M.L.
  3. Morillas, R.M.
  4. García-Retortillo, M.
  5. Martín, L.
  6. Prieto, M.
  7. Gutiérrez, M.L.
  8. Suárez, E.
  9. Gómez Rubio, M.
  10. López, J.
  11. Castillo, P.
  12. Rodríguez, M.
  13. Zozaya, J.M.
  14. Simón, M.A.
  15. Morano, L.E.
  16. Calleja, J.L.
  17. Yébenes, M.
  18. Esteban, R.
Zeitschrift:
PLoS ONE

ISSN: 1932-6203

Datum der Publikation: 2018

Ausgabe: 13

Nummer: 6

Art: Erratum

DOI: 10.1371/JOURNAL.PONE.0199926 GOOGLE SCHOLAR lock_openOpen Access editor

Ziele für nachhaltige Entwicklung